We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pfizer is advancing talks to acquire the U.S. cancer drug company Medivation for close to $14 billion in an effort to boost its oncology portfolio. Read More
The FDA has asked for more information on the pen injector device used in Sanofi and Zealand Pharma's IGlarLixi combination product for diabetes, and extended its review by three months, hurting its chances to be the first product of its kind on the U.S. market. Read More
The FDA has approved Pfizer’s Troxyca extended-release capsules for oral use in patients who require long-term opioid treatment to manage severe pain. Read More